The subcutaneous Tecentriq has been approved in the UK for all indications that ...
The $1.5bn deal is the largest the newly formed company have performed yet, but ...
The US FDA has granted priority review for Zealand Pharma’s dasiglucagon for hyp...
The Phase III trial for FibroGen’s antibody candidate failed to meet its primary...
Biostax and Immgenuity have entered into an agreement to expedite the developmen...
The EC has granted approval for Merck’s Keytruda regimen for gastric or gastroes...
Researchers have isolated a new strain of marine bacteria with unique characteri...
Here's a look at winners and losers from Medicare’s newly released list of drugs...
Medicare announced the first 10 drugs selected for a new drug-price negotiation ...
Medicare has announced the first 10 medicines that will be up first in its new d...
Advance directives were born in the Senate. Now they can help preserve the digni...
Insulet filed a lawsuit this month against its rival EOFlow for stealing trade s...
Increasing extreme weather events compound the poor quality and availability of ...
Researchers envision that whole genome tests eventually will be used for million...
The FDA has postponed its plans to enforce a law designed to thwart counterfeit ...
The U.S. Federal Trade Commission suspended its challenge to Amgen's $27.8 billi...
